Skip to main content
. Author manuscript; available in PMC: 2022 Apr 27.
Published in final edited form as: J Am Coll Cardiol. 2021 Apr 27;77(16):1977–1990. doi: 10.1016/j.jacc.2021.02.058

FIGURE 1. Cumulative Incidence of the Benefit Outcomes and Risk for Adverse Events for Intensive Versus Standard Systolic Blood Pressure Treatment Within Tertiles of Predicted Benefit and Risk for Adverse Events.

FIGURE 1

Shown are the cumulative hazards for the primary outcome (a composite of myocardial infarction, acute coronary syndrome, stroke, heart failure, or death due to cardiovascular causes) (A), all-cause mortality (B), and treatment-related adverse events (C) for intensive versus standard systolic blood pressure treatment within strata of predicted benefit and tertiles of risk for adverse events. CVD = cardiovascular disease.